<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="157859">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01044589</url>
  </required_header>
  <id_info>
    <org_study_id>09-008</org_study_id>
    <nct_id>NCT01044589</nct_id>
  </id_info>
  <brief_title>Comparison of the Efficacy of a Biological Implant to Reinforce Overlapping Sphincter Repair Versus Overlapping Sphincter Repair Alone</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Massarat Zutshi</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Cook</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>The Cleveland Clinic</source>
  <brief_summary>
    <textblock>
      The aim of this study is to compare the efficacy of Biodesign™ Surgisis® Tissue Graft to
      reinforce an overlapping sphincter repair versus the standard overlapping sphincter repair
      in controlling episodes of incontinence in patients who have fecal incontinence and a defect
      in the anal sphincter.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2010</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Outcomes Assessor</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of incontinence episodes per week</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Quality of Life</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">16</enrollment>
  <condition>Fecal Incontinence</condition>
  <condition>Anal Incontinence</condition>
  <arm_group>
    <arm_group_label>Biodesign Tissue Repair Graft</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Biodesign Tissue Repair Graft</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Overlapping Sphincter Repair</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Control</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Biodesign Tissue Repair Graft</intervention_name>
    <description>Biodesign Tissue Repair Graft reinforcement</description>
    <arm_group_label>Biodesign Tissue Repair Graft</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Overlapping Sphincter Repair</intervention_name>
    <description>Overlapping Sphincter Repair Alone</description>
    <arm_group_label>Biodesign Tissue Repair Graft</arm_group_label>
    <arm_group_label>Overlapping Sphincter Repair</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female

          -  Age 18 years or older

          -  fecal incontinence due to an anterior defect in the external anal sphincter or both
             external and internal anal sphincter muscles

          -  Fecal incontinence severity score of 10 or more

          -  Fecal incontinence episodes of 4 or more over a 2 week period

        Exclusion Criteria:

          -  History of diabetes

          -  History of allergy to porcine derivatives

          -  History of infection in the anal area (abscess, fistula)

          -  History of inflammatory bowel disease

          -  History of hidradenitis suppurativa

          -  History of immunosuppression

          -  History of HIV positivity

          -  History of radiation to the study site within the last 12 months

          -  Patients who cannot travel to keep follow up appointments

          -  Patients who are prisoners

          -  Patients who are mentally handicapped

          -  Patients who are pregnant or plan to become pregnant during the study period, or who
             are currently breastfeeding

          -  Patients with significant posterior pelvic organ prolapse and who would be candidates
             for concomitant treatment.

          -  Patients with a FIQL baseline score of ≤ 4

          -  Patients participating in another clinical trial for the same indication

          -  Patients unwilling to give informed consent
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Cleveland Clinic Foundation</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <lastchanged_date>March 29, 2017</lastchanged_date>
  <firstreceived_date>January 7, 2010</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Cleveland Clinic Foundation</investigator_affiliation>
    <investigator_full_name>Massarat Zutshi</investigator_full_name>
    <investigator_title>Staff</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Fecal Incontinence</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
